Report ID: SQMIG35D2157
Report ID:
SQMIG35D2157 |
Region:
Global |
Published Date: July, 2024
Pages:
219
|
Tables:
155 |
Figures:
78
In January 2024, Kindeva Drug Delivery, in drug-device combination products, has enhanced its analytical services capabilities. This enhancement includes the establishment of a new global business unit that offers both integrated and stand-alone analytical support to the pharmaceutical, biopharmaceutical, and medical device industries.
In November 2023, Resolian has successfully acquired Denali Medpharma, a leading bioanalytical CRO based in China. This acquisition expands Resolian's bioanalysis laboratory operations to include facilities in the U.S., UK, Australia, and China.
In September 2023, Cerba HealthCare has acquired CIRION BioPharma Research, a Canadian contract research laboratory, to bolster its bioanalytical capabilities and facilitate the execution of intricate clinical trials.
Our industry expert will work with you to provide you with customized data in a short amount of time.
REQUEST FREE CUSTOMIZATIONWant to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Report ID: SQMIG35D2157